Corcept Therapeutics Incorporated
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersRedwood City, CA
US patents129
SAM.gov UEIMMA8PS1NF6M8
CAGE code6MB68
Incorporated inDE
LEI529900EO9LUTFMZ7FF90
- Cortisol modulation therapy
- FDA Approved
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
129 US patents granted 2003–2025, 68 of them in the five years to SEP 2025.
Pharmaceuticals 108Organic fine chemistry 17Measurement 2Medical technology 2
- Formulations of dazucorilant, a glucocorticoid receptor modulatorUS 12,370,188 · granted JUL 29, 2025
- Glucocorticoid receptor modulators to treat pancreatic cancerUS 12,370,175 · granted JUL 29, 2025
- Methods for shrinking pituitary tumorsUS 12,336,985 · granted JUN 24, 2025
- Methods for imaging and treatment of somatostatin-receptor positive tumorsUS 12,290,551 · granted MAY 6, 2025
- Glucocorticoid receptor modulators to treat cervical cancerUS 12,285,425 · granted APR 29, 2025
Newest 5 shown · Granted to Corcept Therapeutics Incorporated · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Corcept Therapeutics Incorporated | Redwood City | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


